| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962793 | Vaccine | 2016 | 9 Pages |
Abstract
The high dose + adjuvant (100 μg antigen + AlOH) formulation administered at 0-7-30 days elicited the best immune response profile, including functional antibody responses, through Day 180 and was selected for use in subsequent clinical trials.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Guy de Bruyn, Jamshid Saleh, David Workman, Richard Pollak, Victor Elinoff, Neil J. Fraser, Gigi Lefebvre, Mark Martens, Richard E. Mills, Richard Nathan, Miguel Trevino, Martin van Cleeff, Ginamarie Foglia, Ayca Ozol-Godfrey, Dhaval M. Patel,